Friday Pop Quiz 11/22/2024
A 28-year-old female patient presents with the recent onset of lesions on her right forearm, as shown. She notes that her mother has a history of similar lesions and has a history of pernicious anemia. On examination, she has no lesions elsewhere on her body. Which of the following patient factors is most associated with disease progression in the patient’s condition?
A. Age
B. Family …
A 28-year-old female patient presents with the recent onset of lesions on her right forearm, as shown. She notes that her mother has a history of similar lesions and has a history of pernicious anemia. On examination, she has no lesions elsewhere on her body. Which of the following patient factors is most associated with disease progression in the patient’s condition?
A. Age
B. Family … 
Pentoxifylline is a methyl-xanthine derivative traditionally used to treat symptoms of peripheral vascular disease and has emerged as a valuable therapeutic agent in dermatology for its anti-inflammatory and immunomodulatory properties. We continue our series, Therapeutic Cheat Sheet, with a closer look at pentoxifylline, which is FDA-approved for the treatment of intermittent claudication and is … 
During the 2024 Pigmentary Disorders Exchange Symposium, expert dermatologists discussed and shed light on the evolving therapeutic landscape of pigmentary disorders. They addressed key advances, challenges, and gaps in current knowledge. The panel, which was moderated by Dr. Pearl Grimes, featured Dr. John Harris, Dr. Thierry Passeron, and Dr. Ariel Kauvar.
Dr. Harris kicked off the panel disc … 
Alopecia areata (AA) is a nonscarring alopecia driven by autoreactive cytotoxic CD8 T cells against hair follicle antigens. With an unpredictable clinical course, which can include alopecia totalis and universalis, AA can be debilitating to patients’ quality of life. Historically, glucocorticosteroids, cyclosporine, methotrexate, and azathioprine were used off-label for non-targeted immunosuppre … 
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Pearl E. Grimes, symposium chair and clinical professor of dermatology at the University of California, Los Angeles. Hear the “why” behind the Pigmentary Disorders Exchange Symposium from its founding chair. Learn what Dr. Grimes believes is a common myth about pigmentary disorders. Plus hear what m … 